Milestone Pharmaceuticals Inc.
MIST
$1.51
-$0.13-7.67%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -51.88% | -35.65% | -14.71% | 5.74% | 30.44% |
| Total Depreciation and Amortization | 7.59% | 5.89% | 6.07% | 6.09% | 8.03% |
| Total Amortization of Deferred Charges | 16.76% | 15.97% | 16.96% | 16.31% | 51.64% |
| Total Other Non-Cash Items | 27.59% | -5.00% | -19.63% | -29.08% | -28.43% |
| Change in Net Operating Assets | -26.59% | 270.79% | 958.30% | 485.76% | 194.13% |
| Cash from Operations | -70.00% | -35.56% | -9.30% | 18.30% | 37.86% |
| Capital Expenditure | -815.15% | 2.38% | 23.21% | 51.25% | 70.54% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 38.86% | 946.79% | 573.39% | 232.17% | 70.83% |
| Cash from Investing | 35.77% | 961.98% | 571.30% | 231.89% | 74.16% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 198.90% | 67.85% | -99.02% | -99.15% | 4,668.56% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -44.27% | -44.27% | -100.00% | -102.51% | 265.48% |
| Cash from Financing | 166.28% | 53.03% | -99.15% | -100.20% | -32.79% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 313.12% | 1,060.48% | 251.26% | 154.77% | 88.67% |